Review



primary antibodies for periostin  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Novus Biologicals primary antibodies for periostin
    Primary Antibodies For Periostin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Periostin%2FOSF-2+Antibody+-+C-terminus+-+Azide+and+BSA+Free/pm34018851-58-0-4
    Average 94 stars, based on 37 article reviews
    primary antibodies for periostin - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Next-Generation Sequencing:

    Article Title: Collagen type VI regulates TGF-β bioavailability in skeletal muscle in mice
    Article Snippet: Confocal microscopy was performed on a Leica TCS SP5 II confocal microscope. .. The primary antibodies and dilutions were as follows: dystrophin, Sigma-Aldrich D8403 (MANDRA1), mouse IgG1 (1:100 in 5% NGS); collagen VI, Abcam ab6588, rabbit (1:200 in 5% NGS); p-SMAD3, Abcam ab52903, rabbit (1:100 in 10% FBS); LTBP4, R&D Systems AF2885, goat (1:100 in 5% NGS); myosin heavy chain I (MyoHC I), Developmental Studies Hybridoma Bank (DSHB; Iowa City, Iowa, USA) BA-D5, mouse IgG2b (1:20 in 5% NGS); MyoHC IIa, DSHB SC-71, mouse IgG1 (1:20 in 5% NGS); MyoHC IIb, DSHB BF-F3, mouse IgM (1:20 in 5% NGS); periostin, Novus NBP1-30042, rabbit (1:100 in 10% FBS); fibronectin, Sigma-Aldrich F3648, rabbit (1:200 in 10% FBS). ..

    Article Title: Collagen type VI regulates TGF- β bioavailability in skeletal muscle in mice
    Article Snippet: Confocal microscopy was performed on a Leica TCS SP5 II confocal microscope. .. The primary antibodies and dilutions were as follows: dystrophin, Sigma-Aldrich D8403 (MANDRA1), mouse IgG1 (1:100 in 5% NGS); collagen VI, Abcam ab6588, rabbit (1:200 in 5% NGS); p-SMAD3, Abcam ab52903, rabbit (1:100 in 10% FBS); LTBP4, R&D Systems AF2885, goat (1:100 in 5% NGS); myosin heavy chain I (MyoHC I), Developmental Studies Hybridoma Bank (DSHB; Iowa City, Iowa, USA) BA-D5, mouse IgG2b (1:20 in 5% NGS); MyoHC IIa, DSHB SC-71, mouse IgG1 (1:20 in 5% NGS); MyoHC IIb, DSHB BF-F3, mouse IgM (1:20 in 5% NGS); periostin, Novus NBP1-30042, rabbit (1:100 in 10% FBS); fibronectin, Sigma-Aldrich F3648, rabbit (1:200 in 10% FBS). .. We quantified the fibrotic area of the muscle using the Sirius red stain images by splitting the RGB channels, thresholding the green channel, highlighting the extracellular fibrillar collagen content, and measuring the percentage area limited to threshold in Fiji/ImageJ ( http://imagej.nih.gov/ij/ ).

    Western Blot:

    Article Title: Collagen type VI regulates TGF-β bioavailability in skeletal muscle in mice
    Article Snippet: Densitometry of the bands was performed with Fiji/ImageJ. .. Antibodies and their dilutions used in Western blotting were as follows: collagen VI, Abcam ab6588, rabbit (1:1,000 in 5% BSA); p-SMAD3, Epitomics 1880-1, rabbit (1:500 in 5% BSA); SMAD3, Cell Signaling 9513, rabbit (1:500 in 5% BSA); TGF-β1, R&D Systems MAB240, mouse (1:500 in 5% BSA); GAPDH, EMD Millipore MAB374, mouse (1:5,000 in 5% milk); fibronectin, Sigma-Aldrich F3648, rabbit (1:2,500 in Intercept); periostin, Novus NBP1-30042, rabbit (1:1,000 in 5% milk). ..

    Article Title: Collagen type VI regulates TGF- β bioavailability in skeletal muscle in mice
    Article Snippet: Densitometry of the bands was performed with Fiji/ImageJ. .. Antibodies and their dilutions used in Western blotting were as follows: collagen VI, Abcam ab6588, rabbit (1:1,000 in 5% BSA); p-SMAD3, Epitomics 1880-1, rabbit (1:500 in 5% BSA); SMAD3, Cell Signaling 9513, rabbit (1:500 in 5% BSA); TGF-β1, R&D Systems MAB240, mouse (1:500 in 5% BSA); GAPDH, EMD Millipore MAB374, mouse (1:5,000 in 5% milk); fibronectin, Sigma-Aldrich F3648, rabbit (1:2,500 in Intercept); periostin, Novus NBP1-30042, rabbit (1:1,000 in 5% milk). .. Protein samples were prepared using the NativePAGE sample preparation kit (Thermo Fisher Scientific, BN2008) in 1% digitonin or 1% NP-40.

    Incubation:

    Article Title: WISP1 drives a mechanically active immune modulatory and proliferative cardiac myofibroblast state
    Article Snippet: Four micrograms of protein per lane were resolved on 10% TGX Stain-Free gels (Bio-Rad, 4568035), transferred to nitrocellulose membranes, and blocked in 5% BSA (MilliporeSigma, A7906) in Tween-Tris Buffered Saline (T-TBS) for 1 h at room temperature. .. Membranes were incubated overnight at 4 °C with primary antibodies (1:1,000 in 5% BSA): Periostin (Novus Biologicals, NBP1-30042), α-SMA (Cell Signaling, D4K9N), Col1a1 (Cell Signaling, E8F47), Fibronectin (Cell Signaling, E7F5X), and GAPDH (Cell Signaling, 14C10). .. HRP-conjugated anti-rabbit secondary antibody (Bio-Rad, 1721019; 1:10,000) was applied for 1 h at room temperature.

    Article Title: <scp>HuR</scp> inhibition reduces post‐ischemic cardiac remodeling by dampening myocyte‐dependent inflammatory gene expression and the innate immune response
    Article Snippet: .. Primary antibodies for HuR (Abcam, ab200342; 1:2000), Periostin (Novus, NBP1- 30042; 1:1000), Histone H3 (Cell Signaling, 4499S; 1:1000), CD68 (BioRad, MCA1957; 1:500), and GAPDH (Cell Signaling, 2118S; 1:2000) were incubated overnight at 4°C in 5% BSA, and secondary antibodies (1:5000) were incubated for 1 h at room temperature in 5% BSA. ..

    Article Title: TXNDC5 Governs Extracellular Matrix Homeostasis in Pulmonary Hypertension
    Article Snippet: .. After blocking, the sections 126 were incubated with primary antibodies at 4°C overnight (TXNDC5, Proteintech, 127 19834-1-AP, 1:200; α-SMA, Cell Signaling Technology, 19245S, 1:200; CD31, 128 Dianova, DIA-310, 1:100; BGN, Proteintech, 16409-1-AP, 1:100; POSTN, Novus, 129 NBP1-30042, 1:100; LOX, ABclonal, A11504, 1:100; TGM2, ABclonal, A0981, 130 1:100). ..

    other:

    Article Title: Cardiomyocyte-expressed TGFβ signals to fibroblasts to program early heart maturation and adult myocyte identity
    Article Snippet: Briefly, fixed tissue sections were blocked with streptavidin and biotin reagents (Thermo Fisher Scientific, E21390) according to the manufacturer’s instructions with incubation in component A for 30 minutes and component B for 30 minutes both at 370 C in a humidified chamber.

    Blocking Assay:

    Article Title: TXNDC5 Governs Extracellular Matrix Homeostasis in Pulmonary Hypertension
    Article Snippet: .. After blocking, the sections 126 were incubated with primary antibodies at 4°C overnight (TXNDC5, Proteintech, 127 19834-1-AP, 1:200; α-SMA, Cell Signaling Technology, 19245S, 1:200; CD31, 128 Dianova, DIA-310, 1:100; BGN, Proteintech, 16409-1-AP, 1:100; POSTN, Novus, 129 NBP1-30042, 1:100; LOX, ABclonal, A11504, 1:100; TGM2, ABclonal, A0981, 130 1:100). ..

    Cell-Signaling:

    Article Title: TXNDC5 Governs Extracellular Matrix Homeostasis in Pulmonary Hypertension
    Article Snippet: .. After blocking, the sections 126 were incubated with primary antibodies at 4°C overnight (TXNDC5, Proteintech, 127 19834-1-AP, 1:200; α-SMA, Cell Signaling Technology, 19245S, 1:200; CD31, 128 Dianova, DIA-310, 1:100; BGN, Proteintech, 16409-1-AP, 1:100; POSTN, Novus, 129 NBP1-30042, 1:100; LOX, ABclonal, A11504, 1:100; TGM2, ABclonal, A0981, 130 1:100). ..

    Data-independent acquisition:

    Article Title: TXNDC5 Governs Extracellular Matrix Homeostasis in Pulmonary Hypertension
    Article Snippet: .. After blocking, the sections 126 were incubated with primary antibodies at 4°C overnight (TXNDC5, Proteintech, 127 19834-1-AP, 1:200; α-SMA, Cell Signaling Technology, 19245S, 1:200; CD31, 128 Dianova, DIA-310, 1:100; BGN, Proteintech, 16409-1-AP, 1:100; POSTN, Novus, 129 NBP1-30042, 1:100; LOX, ABclonal, A11504, 1:100; TGM2, ABclonal, A0981, 130 1:100). ..



    Similar Products

    92
    R&D Systems α5 gabaar
    α5 Gabaar, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Mouse%2FRat+GABA-A+R+alpha+5+C-Terminus+Antibody/pm42776198-92-8-12
    Average 92 stars, based on 1 article reviews
    α5 gabaar - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    95
    NeuroMab mouse monoclonal anti total lrrk2 mouse
    A) Summary of donor participants; neutrophils and monocytes were isolated from six members of the affected family, including 1 VPS35 p.A320V carrier with PD (individual III.3), four NMC VPS35 p.A320V (individuals IV.2, IV.5, IV.6, and V.1), and one non-variant carrier (individual IV.7). An additional four un-related, non-mutation carriers were also included as controls (individuals D01, D02, D03, and D04). A-B) Immunoblot analysis was performed with 20 μg of protein from neutrophil and monocyte samples. Neutrophils and monocytes were treated with a <t>LRRK2-specific</t> small-molecule inhibitor, MLi2 (200 nM), or a vehicle control for 30 minutes prior to lysis. C-F) Quantification of <t>LRRK2</t> activity with neutrophils and monocytes by immunoblot analysis and targeted mass spectrometry (MS). PT73-Rab10 levels / total Rab10 levels were normalized to the average of non-carrier (vehicle-treated control) samples. LRRK2 activity was reported as fold-change relative to the average of non-carrier (vehicle-treated controls) samples. Data were analy z ed using Welch’s t-test. pT73-Rab10 levels were not significantly elevated in neutrophils or monocytes collected from A320V mutation carriers (n=5) compared to non-mutation carriers (n=5).
    Mouse Monoclonal Anti Total Lrrk2 Mouse, supplied by NeuroMab, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Anti-LRRK2%2FDardarin%2C+C-Terminus+Antibody/med_rxiv__64898__2026__08__21__26358613-55-0-5
    Average 95 stars, based on 1 article reviews
    mouse monoclonal anti total lrrk2 mouse - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    NeuroMab lrrk2
    a Schematic diagram of the experimental design. Mice were fed with normal chow diet (23.7% Kcal from fat) for 11 months, then they were randomly divided into high-fat diet (60% Kcal from fat) or control diet (10% Kcal from fat) groups, the mice were kept on their specific diets for an additional five months. Behavioral tests were conducted before the diet switch and again four months afterward. Body weight was measured biweekly. Fasting blood glucose and plasma insulin levels were measured two weeks prior to euthanasia. At the age of 16 months old, plasma, brain, liver, lung, and kidney were collected and subjected to biochemical and histological analysis. b Body weight changes along with 20 weeks of specific diet feeding ( n = 10–14 per group). c Blood glucose and d Plasma insulin level at 20 weeks post specific diet feeding ( n = 10–14 per group). e , f Volcano plot showing differences in the abundance of lipids between HFD and Con.diet in the plasma of G2019S <t>LRRK2</t> knockin mice and wild-type controls, each point represents a lipid species. X-axis shows log 2 (fold change) in lipid abundance between high-fat diet and control diet groups. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Lipids with adjusted P < 0.05 are considered significantly altered. Significantly upregulated lipids are highlighted in red and significantly downregulated lipids are highlighted in blue. g Representative images of Hematoxylin and Eosin (H&E) staining of the livers collected at the terminal stage, scale bar: 100 µm. h Quantification of lipid area in H&E-stained liver sections ( n = 3–4 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S <t>LRRK2</t> knockin mice; TG, triglycerides; LPC, lysophosphatidylcholine. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Lrrk2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Anti-LRRK2%2FDardarin%2C+C-Terminus+Antibody/pmc13724748-489-7-9
    Average 95 stars, based on 1 article reviews
    lrrk2 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    86
    Sangon Biotech c terminus
    a Schematic diagram of the experimental design. Mice were fed with normal chow diet (23.7% Kcal from fat) for 11 months, then they were randomly divided into high-fat diet (60% Kcal from fat) or control diet (10% Kcal from fat) groups, the mice were kept on their specific diets for an additional five months. Behavioral tests were conducted before the diet switch and again four months afterward. Body weight was measured biweekly. Fasting blood glucose and plasma insulin levels were measured two weeks prior to euthanasia. At the age of 16 months old, plasma, brain, liver, lung, and kidney were collected and subjected to biochemical and histological analysis. b Body weight changes along with 20 weeks of specific diet feeding ( n = 10–14 per group). c Blood glucose and d Plasma insulin level at 20 weeks post specific diet feeding ( n = 10–14 per group). e , f Volcano plot showing differences in the abundance of lipids between HFD and Con.diet in the plasma of G2019S <t>LRRK2</t> knockin mice and wild-type controls, each point represents a lipid species. X-axis shows log 2 (fold change) in lipid abundance between high-fat diet and control diet groups. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Lipids with adjusted P < 0.05 are considered significantly altered. Significantly upregulated lipids are highlighted in red and significantly downregulated lipids are highlighted in blue. g Representative images of Hematoxylin and Eosin (H&E) staining of the livers collected at the terminal stage, scale bar: 100 µm. h Quantification of lipid area in H&E-stained liver sections ( n = 3–4 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S <t>LRRK2</t> knockin mice; TG, triglycerides; LPC, lysophosphatidylcholine. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    C Terminus, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/c+terminus/pm42265791-85-21-26
    Average 86 stars, based on 1 article reviews
    c terminus - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    RayBiotech inc goat anti human cystatin b stefin b
    a Schematic diagram of the experimental design. Mice were fed with normal chow diet (23.7% Kcal from fat) for 11 months, then they were randomly divided into high-fat diet (60% Kcal from fat) or control diet (10% Kcal from fat) groups, the mice were kept on their specific diets for an additional five months. Behavioral tests were conducted before the diet switch and again four months afterward. Body weight was measured biweekly. Fasting blood glucose and plasma insulin levels were measured two weeks prior to euthanasia. At the age of 16 months old, plasma, brain, liver, lung, and kidney were collected and subjected to biochemical and histological analysis. b Body weight changes along with 20 weeks of specific diet feeding ( n = 10–14 per group). c Blood glucose and d Plasma insulin level at 20 weeks post specific diet feeding ( n = 10–14 per group). e , f Volcano plot showing differences in the abundance of lipids between HFD and Con.diet in the plasma of G2019S <t>LRRK2</t> knockin mice and wild-type controls, each point represents a lipid species. X-axis shows log 2 (fold change) in lipid abundance between high-fat diet and control diet groups. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Lipids with adjusted P < 0.05 are considered significantly altered. Significantly upregulated lipids are highlighted in red and significantly downregulated lipids are highlighted in blue. g Representative images of Hematoxylin and Eosin (H&E) staining of the livers collected at the terminal stage, scale bar: 100 µm. h Quantification of lipid area in H&E-stained liver sections ( n = 3–4 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S <t>LRRK2</t> knockin mice; TG, triglycerides; LPC, lysophosphatidylcholine. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Goat Anti Human Cystatin B Stefin B, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Goat+Anti-Human+Cystatin+b+%2F+Stefin+B+(C-Terminus)/us12631655-302-26-34
    Average 94 stars, based on 1 article reviews
    goat anti human cystatin b stefin b - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Boster Bio crp
    <t>HDAC2</t> enhances antimicrobial activities against E.coli in mice. (A) Bacterial loads in the blood were calculated in HDAC2-knockout and wild type mice. (A)The picture of the bacterial clones was taken by BIO-RAD ChemiDoc“MP Imaging System. (B)The number of colony-forming units (CFU) in the blood of mice was calculated. HDAC2 WT and HDAC2 KO mice were administrated with E. coli- GFP (5 × 10 7 ) by intravenous Injection. Blood (20 μl) was taken from the tail vein of the mice, applied to the pretreated solid MHA medium, and incubated at 37 °C for 20 h. Count the colonies on the culture medium and take pictures. The experiments were performed in quintuplicate, data are presented as the means ± SEM. of independent experiments. *P < 0.05, **P < 0.01 (two-tailed Student’s t -test). (B) Bacterial loads in the kidneys were calculated in HDAC2-knockout and wild type mice. The picture of kidneys from HDAC2 WT and HDAC2 KO mice were taken. The number of colony-forming units (CFU) in the kidneys of mice was calculated. The kidneys from HDAC2 KO and HDAC2 WT mice were weighed, ground, spread on the MHA plates, incubated for 16–24 h at 37 °C, and then bacterial clones were counted. The experiments were performed in quintuplicate, data are presented as the means ± SEM. of independent experiments. *P < 0.05, **P < 0.01 (two-tailed Student’s t -test). n = 5 mice per group. (C) H&E staining of livers and kidneys. The arrows indicate damage section of tissue. (D) Serum <t>CRP</t> and PCT levels of mice with E. coli- GFP bacteremia at 24 h. The CRP and PCT were measured by ELISA. Data are shown as mean ± SEM. *p < 0.05; n = 5 mice per group. ns, not significant.
    Crp, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Anti-HDAC-2+(C-terminus)+Antibody/pmc13131401-117-12-36
    Average 93 stars, based on 1 article reviews
    crp - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    86
    Pacific Immunology anti c terminus antibody
    The cleaved form of <t>the</t> <t>Cav1.3-C-terminus</t> is localized within the nucleus. ( A ) Schematic representation of the Cav1.3 α1 subunit with the four domains (I–IV), six repeat segments (1–6), pore region (P), N-terminus (brown), intracellular loops (IC, green) and the C-terminus (C-term, blue) with the relevant regulatory domains (Isoleucine-glutamine (IQ); EF-Helix binding motif (EF hand)). The commercial anti-II-III loop and <t>anti-C-terminus</t> antibodies’ epitope are shown in red. Anti-Ca v 1.3-C-terminus antibody labeling shows green fluorescent staining of the nucleus and the cytoplasm in ( B ) non-infected neonatal rat myocytes (NRVMs), ( E ) non-infected adult rat atrial myocytes (ARAMs) and ( H ) Ca v 1.3-transfected tsA201 cells. DAPI in blue ( C , F ) and red ( I ) is a nuclear staining marker. Arrows indicate nuclear staining. Overlay images are shown in ( D , G , J ). The scale bar is 20 μm. ( K ) Surface plot illustrating the staining intensity of the C-terminus in the nucleus and cytoplasm using the anti-C-terminus antibody. The central gray peak corresponds to nuclear green fluorescence. ( L ) Representative Western blots of nuclear and cyptoplasmic fractions from non-infected NRVMs and ARAMs probed with the C-terminus antibody (n = 5). Histone Deacetylase (HDAC) and Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) were used as internal controls.
    Anti C Terminus Antibody, supplied by Pacific Immunology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/anti+c+terminus/pmc13162661-115-16-18
    Average 86 stars, based on 1 article reviews
    anti c terminus antibody - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Boster Bio myeloperoxidase mpo
    The cleaved form of <t>the</t> <t>Cav1.3-C-terminus</t> is localized within the nucleus. ( A ) Schematic representation of the Cav1.3 α1 subunit with the four domains (I–IV), six repeat segments (1–6), pore region (P), N-terminus (brown), intracellular loops (IC, green) and the C-terminus (C-term, blue) with the relevant regulatory domains (Isoleucine-glutamine (IQ); EF-Helix binding motif (EF hand)). The commercial anti-II-III loop and <t>anti-C-terminus</t> antibodies’ epitope are shown in red. Anti-Ca v 1.3-C-terminus antibody labeling shows green fluorescent staining of the nucleus and the cytoplasm in ( B ) non-infected neonatal rat myocytes (NRVMs), ( E ) non-infected adult rat atrial myocytes (ARAMs) and ( H ) Ca v 1.3-transfected tsA201 cells. DAPI in blue ( C , F ) and red ( I ) is a nuclear staining marker. Arrows indicate nuclear staining. Overlay images are shown in ( D , G , J ). The scale bar is 20 μm. ( K ) Surface plot illustrating the staining intensity of the C-terminus in the nucleus and cytoplasm using the anti-C-terminus antibody. The central gray peak corresponds to nuclear green fluorescence. ( L ) Representative Western blots of nuclear and cyptoplasmic fractions from non-infected NRVMs and ARAMs probed with the C-terminus antibody (n = 5). Histone Deacetylase (HDAC) and Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) were used as internal controls.
    Myeloperoxidase Mpo, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Anti-HDAC-2+(C-terminus)+Antibody/pmc13131401-117-14-36
    Average 93 stars, based on 1 article reviews
    myeloperoxidase mpo - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Boster Bio histone deacetylase 2
    The cleaved form of <t>the</t> <t>Cav1.3-C-terminus</t> is localized within the nucleus. ( A ) Schematic representation of the Cav1.3 α1 subunit with the four domains (I–IV), six repeat segments (1–6), pore region (P), N-terminus (brown), intracellular loops (IC, green) and the C-terminus (C-term, blue) with the relevant regulatory domains (Isoleucine-glutamine (IQ); EF-Helix binding motif (EF hand)). The commercial anti-II-III loop and <t>anti-C-terminus</t> antibodies’ epitope are shown in red. Anti-Ca v 1.3-C-terminus antibody labeling shows green fluorescent staining of the nucleus and the cytoplasm in ( B ) non-infected neonatal rat myocytes (NRVMs), ( E ) non-infected adult rat atrial myocytes (ARAMs) and ( H ) Ca v 1.3-transfected tsA201 cells. DAPI in blue ( C , F ) and red ( I ) is a nuclear staining marker. Arrows indicate nuclear staining. Overlay images are shown in ( D , G , J ). The scale bar is 20 μm. ( K ) Surface plot illustrating the staining intensity of the C-terminus in the nucleus and cytoplasm using the anti-C-terminus antibody. The central gray peak corresponds to nuclear green fluorescence. ( L ) Representative Western blots of nuclear and cyptoplasmic fractions from non-infected NRVMs and ARAMs probed with the C-terminus antibody (n = 5). Histone Deacetylase (HDAC) and Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) were used as internal controls.
    Histone Deacetylase 2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Anti-HDAC-2+(C-terminus)+Antibody/pmc13131401-117-7-36
    Average 93 stars, based on 1 article reviews
    histone deacetylase 2 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Boster Bio interleukin 6
    The cleaved form of <t>the</t> <t>Cav1.3-C-terminus</t> is localized within the nucleus. ( A ) Schematic representation of the Cav1.3 α1 subunit with the four domains (I–IV), six repeat segments (1–6), pore region (P), N-terminus (brown), intracellular loops (IC, green) and the C-terminus (C-term, blue) with the relevant regulatory domains (Isoleucine-glutamine (IQ); EF-Helix binding motif (EF hand)). The commercial anti-II-III loop and <t>anti-C-terminus</t> antibodies’ epitope are shown in red. Anti-Ca v 1.3-C-terminus antibody labeling shows green fluorescent staining of the nucleus and the cytoplasm in ( B ) non-infected neonatal rat myocytes (NRVMs), ( E ) non-infected adult rat atrial myocytes (ARAMs) and ( H ) Ca v 1.3-transfected tsA201 cells. DAPI in blue ( C , F ) and red ( I ) is a nuclear staining marker. Arrows indicate nuclear staining. Overlay images are shown in ( D , G , J ). The scale bar is 20 μm. ( K ) Surface plot illustrating the staining intensity of the C-terminus in the nucleus and cytoplasm using the anti-C-terminus antibody. The central gray peak corresponds to nuclear green fluorescence. ( L ) Representative Western blots of nuclear and cyptoplasmic fractions from non-infected NRVMs and ARAMs probed with the C-terminus antibody (n = 5). Histone Deacetylase (HDAC) and Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) were used as internal controls.
    Interleukin 6, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+terminus/Anti-HDAC-2+(C-terminus)+Antibody/pmc13131401-117-5-36
    Average 93 stars, based on 1 article reviews
    interleukin 6 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    A) Summary of donor participants; neutrophils and monocytes were isolated from six members of the affected family, including 1 VPS35 p.A320V carrier with PD (individual III.3), four NMC VPS35 p.A320V (individuals IV.2, IV.5, IV.6, and V.1), and one non-variant carrier (individual IV.7). An additional four un-related, non-mutation carriers were also included as controls (individuals D01, D02, D03, and D04). A-B) Immunoblot analysis was performed with 20 μg of protein from neutrophil and monocyte samples. Neutrophils and monocytes were treated with a LRRK2-specific small-molecule inhibitor, MLi2 (200 nM), or a vehicle control for 30 minutes prior to lysis. C-F) Quantification of LRRK2 activity with neutrophils and monocytes by immunoblot analysis and targeted mass spectrometry (MS). PT73-Rab10 levels / total Rab10 levels were normalized to the average of non-carrier (vehicle-treated control) samples. LRRK2 activity was reported as fold-change relative to the average of non-carrier (vehicle-treated controls) samples. Data were analy z ed using Welch’s t-test. pT73-Rab10 levels were not significantly elevated in neutrophils or monocytes collected from A320V mutation carriers (n=5) compared to non-mutation carriers (n=5).

    Journal: medRxiv

    Article Title: The VPS35 p.A320V variant segregates with Parkinson’s disease in a pesticide-exposed family

    doi: 10.64898/2026.08.21.26358613

    Figure Lengend Snippet: A) Summary of donor participants; neutrophils and monocytes were isolated from six members of the affected family, including 1 VPS35 p.A320V carrier with PD (individual III.3), four NMC VPS35 p.A320V (individuals IV.2, IV.5, IV.6, and V.1), and one non-variant carrier (individual IV.7). An additional four un-related, non-mutation carriers were also included as controls (individuals D01, D02, D03, and D04). A-B) Immunoblot analysis was performed with 20 μg of protein from neutrophil and monocyte samples. Neutrophils and monocytes were treated with a LRRK2-specific small-molecule inhibitor, MLi2 (200 nM), or a vehicle control for 30 minutes prior to lysis. C-F) Quantification of LRRK2 activity with neutrophils and monocytes by immunoblot analysis and targeted mass spectrometry (MS). PT73-Rab10 levels / total Rab10 levels were normalized to the average of non-carrier (vehicle-treated control) samples. LRRK2 activity was reported as fold-change relative to the average of non-carrier (vehicle-treated controls) samples. Data were analy z ed using Welch’s t-test. pT73-Rab10 levels were not significantly elevated in neutrophils or monocytes collected from A320V mutation carriers (n=5) compared to non-mutation carriers (n=5).

    Article Snippet: Mouse monoclonal anti-total LRRK2 mouse (NeuroMab #75-253) and rabbit monoclonal anti-pS935 LRRK2 (ab133450) were used at a final concentration of 1 μg/mL and were purified in-house as described previously.

    Techniques: Isolation, Variant Assay, Mutagenesis, Western Blot, Control, Lysis, Activity Assay, Mass Spectrometry

    a Schematic diagram of the experimental design. Mice were fed with normal chow diet (23.7% Kcal from fat) for 11 months, then they were randomly divided into high-fat diet (60% Kcal from fat) or control diet (10% Kcal from fat) groups, the mice were kept on their specific diets for an additional five months. Behavioral tests were conducted before the diet switch and again four months afterward. Body weight was measured biweekly. Fasting blood glucose and plasma insulin levels were measured two weeks prior to euthanasia. At the age of 16 months old, plasma, brain, liver, lung, and kidney were collected and subjected to biochemical and histological analysis. b Body weight changes along with 20 weeks of specific diet feeding ( n = 10–14 per group). c Blood glucose and d Plasma insulin level at 20 weeks post specific diet feeding ( n = 10–14 per group). e , f Volcano plot showing differences in the abundance of lipids between HFD and Con.diet in the plasma of G2019S LRRK2 knockin mice and wild-type controls, each point represents a lipid species. X-axis shows log 2 (fold change) in lipid abundance between high-fat diet and control diet groups. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Lipids with adjusted P < 0.05 are considered significantly altered. Significantly upregulated lipids are highlighted in red and significantly downregulated lipids are highlighted in blue. g Representative images of Hematoxylin and Eosin (H&E) staining of the livers collected at the terminal stage, scale bar: 100 µm. h Quantification of lipid area in H&E-stained liver sections ( n = 3–4 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice; TG, triglycerides; LPC, lysophosphatidylcholine. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: a Schematic diagram of the experimental design. Mice were fed with normal chow diet (23.7% Kcal from fat) for 11 months, then they were randomly divided into high-fat diet (60% Kcal from fat) or control diet (10% Kcal from fat) groups, the mice were kept on their specific diets for an additional five months. Behavioral tests were conducted before the diet switch and again four months afterward. Body weight was measured biweekly. Fasting blood glucose and plasma insulin levels were measured two weeks prior to euthanasia. At the age of 16 months old, plasma, brain, liver, lung, and kidney were collected and subjected to biochemical and histological analysis. b Body weight changes along with 20 weeks of specific diet feeding ( n = 10–14 per group). c Blood glucose and d Plasma insulin level at 20 weeks post specific diet feeding ( n = 10–14 per group). e , f Volcano plot showing differences in the abundance of lipids between HFD and Con.diet in the plasma of G2019S LRRK2 knockin mice and wild-type controls, each point represents a lipid species. X-axis shows log 2 (fold change) in lipid abundance between high-fat diet and control diet groups. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Lipids with adjusted P < 0.05 are considered significantly altered. Significantly upregulated lipids are highlighted in red and significantly downregulated lipids are highlighted in blue. g Representative images of Hematoxylin and Eosin (H&E) staining of the livers collected at the terminal stage, scale bar: 100 µm. h Quantification of lipid area in H&E-stained liver sections ( n = 3–4 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice; TG, triglycerides; LPC, lysophosphatidylcholine. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Control, Clinical Proteomics, Analysis, Knock-In, Staining, Mutagenesis

    Behavioral tests were conducted four months after the initiation of diet switch ( n = 5–8 per group). a – d Open field test. a Scheme and dimensions of the open field apparatus; b Total distance traveled (m) during the 15-min open field test; c Distance traveled in center zone of total distance of the open field test during 15-min session; d Entries in central zone (frequency) during the 15-min open field test. e – l Catwalk gait analysis. e Average speed (cm/s); f – i Stand time of each paw (s), LF, left front; RF, right front; LH, left hind; RF, right hind. j Cadence (steps/s); k , i Base of support; m – p Elevated plus maze. m Scheme and annotation of the elevated plus maze apparatus; n Time spend (s) in open arm of elevated plus maze during the 10-min test; o Entries in open arms (frequency) of elevated plus maze during the 10-min test; p Ratio of distance traveled in the open arms and center zone relative to the total distance during the elevated plus maze. q , r Y-maze. q Scheme and annotation of the Y-maze apparatus; r Spontaneous alternation (%) calculated in the 10-min Y-maze test. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: Behavioral tests were conducted four months after the initiation of diet switch ( n = 5–8 per group). a – d Open field test. a Scheme and dimensions of the open field apparatus; b Total distance traveled (m) during the 15-min open field test; c Distance traveled in center zone of total distance of the open field test during 15-min session; d Entries in central zone (frequency) during the 15-min open field test. e – l Catwalk gait analysis. e Average speed (cm/s); f – i Stand time of each paw (s), LF, left front; RF, right front; LH, left hind; RF, right hind. j Cadence (steps/s); k , i Base of support; m – p Elevated plus maze. m Scheme and annotation of the elevated plus maze apparatus; n Time spend (s) in open arm of elevated plus maze during the 10-min test; o Entries in open arms (frequency) of elevated plus maze during the 10-min test; p Ratio of distance traveled in the open arms and center zone relative to the total distance during the elevated plus maze. q , r Y-maze. q Scheme and annotation of the Y-maze apparatus; r Spontaneous alternation (%) calculated in the 10-min Y-maze test. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Open Field Test, Gait and locomotion, EPM Assay, Knock-In, Mutagenesis

    a , d , g Representative images of Iba1 immunostaining in the striatum ( a ), substantia nigra ( d ), and hypothalamus ( g ) showing microglial distribution. Scale bar: 100 µm. b , e , h Quantification of Iba1-positive microglial counts relative to area in the striatum ( b ), substantia nigra ( e ), and hypothalamus ( h ). c , f , i Quantification of average microglial soma area (µm²) in the striatum ( c ), substantia nigra ( f ), and hypothalamus ( i ) ( n = 5–6 per group). j Representative images of GFAP immunostaining in the hypothalamus showing astrocytes distribution. Scale bar: 100 µm. k Quantification of GFAP-positive area in the hypothalamus ( n = 5–6 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: a , d , g Representative images of Iba1 immunostaining in the striatum ( a ), substantia nigra ( d ), and hypothalamus ( g ) showing microglial distribution. Scale bar: 100 µm. b , e , h Quantification of Iba1-positive microglial counts relative to area in the striatum ( b ), substantia nigra ( e ), and hypothalamus ( h ). c , f , i Quantification of average microglial soma area (µm²) in the striatum ( c ), substantia nigra ( f ), and hypothalamus ( i ) ( n = 5–6 per group). j Representative images of GFAP immunostaining in the hypothalamus showing astrocytes distribution. Scale bar: 100 µm. k Quantification of GFAP-positive area in the hypothalamus ( n = 5–6 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Immunostaining, Knock-In, Mutagenesis

    a Representative image of TH immunostaining in the substantia nigra. Scale bar: 500 µm. Quantification of TH-positive neurons ( b ) and Nissl-positive neurons ( c ) in the substantia nigra ( n = 3–7 per group). d Representative images of TH immunostaining in the striatum. Scale bar: 100 µm. e Quantification of TH-positive area in the striatum ( n = 5–6 per group). f Relative striatal dopamine level measured by LC-MS ( n = 5–6 per group). Western blot analysis ( g , h ) and quantification ( i – n ) of LRRK2 and Rab12 expression levels in the striatum ( g , i – k ) and ventral midbrain ( h , l – n ) of G2019S LRRK2 knockin and wild-type mice under control (Con.) diet and HFD conditions ( n = 3 per group). Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001).

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: a Representative image of TH immunostaining in the substantia nigra. Scale bar: 500 µm. Quantification of TH-positive neurons ( b ) and Nissl-positive neurons ( c ) in the substantia nigra ( n = 3–7 per group). d Representative images of TH immunostaining in the striatum. Scale bar: 100 µm. e Quantification of TH-positive area in the striatum ( n = 5–6 per group). f Relative striatal dopamine level measured by LC-MS ( n = 5–6 per group). Western blot analysis ( g , h ) and quantification ( i – n ) of LRRK2 and Rab12 expression levels in the striatum ( g , i – k ) and ventral midbrain ( h , l – n ) of G2019S LRRK2 knockin and wild-type mice under control (Con.) diet and HFD conditions ( n = 3 per group). Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001).

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Immunostaining, Liquid Chromatography with Mass Spectroscopy, Western Blot, Analysis, Expressing, Knock-In, Control, Mutagenesis

    Volcano plot showing differences in the abundance of non-lipid metabolites between G2019S LRRK2 knockin mice and wild-type controls under Con.diet and HFD in the striatum ( a , b ), plasma ( c , d ), liver ( e , f ), lung ( g , h) , and kidney ( i , j ). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Each point represents a non-lipid metabolite. X-axis shows log 2 (fold change) in non-lipid metabolite abundance between G2019S LRRK2 knockin mice and wild-type controls. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Non-lipid metabolites with adjusted P < 0.05 are considered significantly altered. Significantly upregulated ones are highlighted in red and significantly downregulated ones are highlighted in blue.

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: Volcano plot showing differences in the abundance of non-lipid metabolites between G2019S LRRK2 knockin mice and wild-type controls under Con.diet and HFD in the striatum ( a , b ), plasma ( c , d ), liver ( e , f ), lung ( g , h) , and kidney ( i , j ). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Each point represents a non-lipid metabolite. X-axis shows log 2 (fold change) in non-lipid metabolite abundance between G2019S LRRK2 knockin mice and wild-type controls. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Non-lipid metabolites with adjusted P < 0.05 are considered significantly altered. Significantly upregulated ones are highlighted in red and significantly downregulated ones are highlighted in blue.

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Knock-In, Clinical Proteomics, Analysis, Significance Assay

    Thymidine ( a ), deoxyuridine ( b ), deoxycytidine ( c ), deoxyadenosine ( d ), and deoxyguanine ( e ) concentrations in striatum (ng/g). Thymidine ( f ), deoxyuridine ( g ), deoxycytidine ( h ), deoxyadenosine ( i ), and deoxyguanine ( j ) concentrations in ventral midbrain (ng/g). Thymidine ( k ), deoxyuridine ( l ), and deoxycytidine ( m ) concentrations in plasma (ng/ml). Nucleoside quantity was measured by LC-MS ( n = 8–9 per group). Data are presented as mean ± SEM. Unpaired two-tailed Student’s t -test was performed to evaluate the effects of G2019S LRRK2 mutation (* P < 0.05, *** P < 0.001, **** P < 0.0001).

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: Thymidine ( a ), deoxyuridine ( b ), deoxycytidine ( c ), deoxyadenosine ( d ), and deoxyguanine ( e ) concentrations in striatum (ng/g). Thymidine ( f ), deoxyuridine ( g ), deoxycytidine ( h ), deoxyadenosine ( i ), and deoxyguanine ( j ) concentrations in ventral midbrain (ng/g). Thymidine ( k ), deoxyuridine ( l ), and deoxycytidine ( m ) concentrations in plasma (ng/ml). Nucleoside quantity was measured by LC-MS ( n = 8–9 per group). Data are presented as mean ± SEM. Unpaired two-tailed Student’s t -test was performed to evaluate the effects of G2019S LRRK2 mutation (* P < 0.05, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Clinical Proteomics, Liquid Chromatography with Mass Spectroscopy, Two Tailed Test, Mutagenesis

    a – f Bar plot showing comparation of selected metabolites (relative abundance) in the striatum across groups ( n = 5–6 per group). These metabolites reflect alterations in energy metabolism ( a – c ) and nucleotide metabolism ( c – f ). Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction, Tukey’s post hoc test was used for multiple comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001). g , h Volcano plot showing differential gene expression in the striatum between G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions. Each point represents one gene. X-axis shows log 2 (fold change) in gene expression, Y-axis shows −log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Gene expression with adjusted P < 0.05 are considered significantly altered. Significantly downregulated genes are highlighted in blue. i , j Volcano plot illustrates enriched biological processes between G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions as identified by gene set enrichment analysis (GSEA). Each point represents one process, X-axis shows normalized enrichment score, Y-axis shows -log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Significantly upregulated genes are highlighted in red and significantly downregulated genes are highlighted in blue. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice.

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: a – f Bar plot showing comparation of selected metabolites (relative abundance) in the striatum across groups ( n = 5–6 per group). These metabolites reflect alterations in energy metabolism ( a – c ) and nucleotide metabolism ( c – f ). Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction, Tukey’s post hoc test was used for multiple comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001). g , h Volcano plot showing differential gene expression in the striatum between G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions. Each point represents one gene. X-axis shows log 2 (fold change) in gene expression, Y-axis shows −log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Gene expression with adjusted P < 0.05 are considered significantly altered. Significantly downregulated genes are highlighted in blue. i , j Volcano plot illustrates enriched biological processes between G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions as identified by gene set enrichment analysis (GSEA). Each point represents one process, X-axis shows normalized enrichment score, Y-axis shows -log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Significantly upregulated genes are highlighted in red and significantly downregulated genes are highlighted in blue. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice.

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Mutagenesis, Gene Expression, Knock-In, Gene Set Enrichment Analysis

    Nuclei were isolated from ventral midbrain of G2019S LRRK2 knockin mice and their littermates ( n = 4 per group), 34,969 nuclei were recovered in total. a t -SNE map shows 27 classified cell clusters with annotations. b Violin plot shows Lrrk2 expression across clusters. c Heatmap illustrates oxidative phosphorylation pathway enrichment across multiple cell types in various group comparisons. Each square represents a specific comparison (labeled on the right) within a given cell cluster (labeled at the bottom). Red squares indicate positive enrichment scores; blue squares indicate negative enrichment scores. Comparisons with statistically significant (Benjamini–Hochberg adjusted p ) enrichment are marked with stars (* P < 0.05, ** P < 0.01, **** P < 0.0001). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice.

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: Nuclei were isolated from ventral midbrain of G2019S LRRK2 knockin mice and their littermates ( n = 4 per group), 34,969 nuclei were recovered in total. a t -SNE map shows 27 classified cell clusters with annotations. b Violin plot shows Lrrk2 expression across clusters. c Heatmap illustrates oxidative phosphorylation pathway enrichment across multiple cell types in various group comparisons. Each square represents a specific comparison (labeled on the right) within a given cell cluster (labeled at the bottom). Red squares indicate positive enrichment scores; blue squares indicate negative enrichment scores. Comparisons with statistically significant (Benjamini–Hochberg adjusted p ) enrichment are marked with stars (* P < 0.05, ** P < 0.01, **** P < 0.0001). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice.

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Isolation, Knock-In, Expressing, Phospho-proteomics, Comparison, Labeling

    a Diagram showing that thymidine phosphorylase catalyzes the conversion of thymidine and deoxyuridine into their respective bases (thymine and uracil) and 2-deoxyribose 1-phosphate. b Western blot analysis of thymidine phosphorylase (TP) expression levels in brain and liver in 5-month-old G2019S LRRK2 knockin mice and controls ( n = 2 per group). c qRT-PCR analysis of TYMP levels in ventral midbrain of 5-month-old G2019S LRRK2 knockin mice and controls ( n = 4 per group). Data are presented as mean ± SEM. Unpaired two-tailed Student’s t -test was performed to evaluate the effects of G2019S LRRK2 mutation, no significant effect was found. d Volcano plot showing differential gene expression in the liver of 5-month-old G2019S LRRK2 knockin mice compared to wild-type controls. Each point represents one gene. X-axis shows log 2 (fold change) in gene expression in G2019S LRRK2 knockin mice compared to wild-type controls. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 4 per group). Gene expression with adjusted P < 0.05 are considered significantly altered. Significantly upregulated genes are highlighted in red and significantly downregulated genes are highlighted in blue. e Volcano plot illustrating enriched biological processes in G2019S LRRK2 knockin mice compared to wild-type controls as identified by gene set enrichment analysis (GSEA). Each point represents one process. X-axis shows normalized enrichment score, Y-axis shows −log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Sig n ificantly upregulated pathways are highlighted in red and significantly downregulated pathways are highlighted in blue. f Western blot analysis and quantification ( g – m ) of TP, total and phosphorylated LRRK2, Rab10, and Rab12 expression levels in the liver of G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions ( n = 3 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: a Diagram showing that thymidine phosphorylase catalyzes the conversion of thymidine and deoxyuridine into their respective bases (thymine and uracil) and 2-deoxyribose 1-phosphate. b Western blot analysis of thymidine phosphorylase (TP) expression levels in brain and liver in 5-month-old G2019S LRRK2 knockin mice and controls ( n = 2 per group). c qRT-PCR analysis of TYMP levels in ventral midbrain of 5-month-old G2019S LRRK2 knockin mice and controls ( n = 4 per group). Data are presented as mean ± SEM. Unpaired two-tailed Student’s t -test was performed to evaluate the effects of G2019S LRRK2 mutation, no significant effect was found. d Volcano plot showing differential gene expression in the liver of 5-month-old G2019S LRRK2 knockin mice compared to wild-type controls. Each point represents one gene. X-axis shows log 2 (fold change) in gene expression in G2019S LRRK2 knockin mice compared to wild-type controls. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 4 per group). Gene expression with adjusted P < 0.05 are considered significantly altered. Significantly upregulated genes are highlighted in red and significantly downregulated genes are highlighted in blue. e Volcano plot illustrating enriched biological processes in G2019S LRRK2 knockin mice compared to wild-type controls as identified by gene set enrichment analysis (GSEA). Each point represents one process. X-axis shows normalized enrichment score, Y-axis shows −log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Sig n ificantly upregulated pathways are highlighted in red and significantly downregulated pathways are highlighted in blue. f Western blot analysis and quantification ( g – m ) of TP, total and phosphorylated LRRK2, Rab10, and Rab12 expression levels in the liver of G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions ( n = 3 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Western Blot, Analysis, Expressing, Knock-In, Quantitative RT-PCR, Two Tailed Test, Mutagenesis, Gene Expression, Gene Set Enrichment Analysis

    a Schematic diagram showing central energy and biosynthetic pathways involving glucose and fatty acids. b – p Bar plot showing comparison of selected metabolites (relative abundance) in lung tissue from G2019S LRRK2 knockin and control mice exposed to either HFD or control diet ( n = 6 mice/group). These metabolites reflect alterations in glycolysis ( b , c ), TCA cycle ( d , e ), pentose phosphate pathway ( f – j ), and nucleotide metabolism ( k – p ). Data are presented as mean ± SEM in bar plot. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 and their interaction, Tukey’s post hoc test was used for multiple comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: a Schematic diagram showing central energy and biosynthetic pathways involving glucose and fatty acids. b – p Bar plot showing comparison of selected metabolites (relative abundance) in lung tissue from G2019S LRRK2 knockin and control mice exposed to either HFD or control diet ( n = 6 mice/group). These metabolites reflect alterations in glycolysis ( b , c ), TCA cycle ( d , e ), pentose phosphate pathway ( f – j ), and nucleotide metabolism ( k – p ). Data are presented as mean ± SEM in bar plot. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 and their interaction, Tukey’s post hoc test was used for multiple comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Comparison, Tissue, Knock-In, Control

    a – c Representative images of H&E staining ( a ), CD68 ( b ), and CD3 ( c ) immunostaining of the lungs. Scale bar: 100 µm. d – g Volcano plot showing differences in the abundance of proteins between HFD and Con.diet groups in wild-type mice ( d ) and G2019S LRRK2 knockin mice ( e ); between G2019S LRRK2 knockin and wild-type mice under Con.diet ( f ) and HFD ( g ) conditions ( n = 4 mice/group). Each point represents a protein. X-axis shows log 2 fold change in protein abundance between each comparison. Y-axis shows −log 10 adjusted p -value from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 4 mice/group). Proteins with adjusted P < 0.05 are considered significantly altered. Significantly upregulated proteins are highlighted in red and significantly downregulated proteins are highlighted in blue. h Western blot analysis and quantification ( i – o ) of total and phosphorated LRRK2, Rab8a, Rab10, and Rab12 expression levels in the lung of G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions ( n = 3 mice/group). WT/WT, wild - type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 and their interaction by Fisher’s LSD comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: a – c Representative images of H&E staining ( a ), CD68 ( b ), and CD3 ( c ) immunostaining of the lungs. Scale bar: 100 µm. d – g Volcano plot showing differences in the abundance of proteins between HFD and Con.diet groups in wild-type mice ( d ) and G2019S LRRK2 knockin mice ( e ); between G2019S LRRK2 knockin and wild-type mice under Con.diet ( f ) and HFD ( g ) conditions ( n = 4 mice/group). Each point represents a protein. X-axis shows log 2 fold change in protein abundance between each comparison. Y-axis shows −log 10 adjusted p -value from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 4 mice/group). Proteins with adjusted P < 0.05 are considered significantly altered. Significantly upregulated proteins are highlighted in red and significantly downregulated proteins are highlighted in blue. h Western blot analysis and quantification ( i – o ) of total and phosphorated LRRK2, Rab8a, Rab10, and Rab12 expression levels in the lung of G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions ( n = 3 mice/group). WT/WT, wild - type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 and their interaction by Fisher’s LSD comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Staining, Immunostaining, Knock-In, Quantitative Proteomics, Comparison, Analysis, Western Blot, Expressing, H&E Stain, Significance Assay

    Thymidine phosphorylase levels were significantly increased in the liver of G2019S LRRK2 knockin mice, leading to systemic depletion of pyrimidine nucleosides, which may contribute to mitochondrial dysfunction. Under control diet conditions, increased mitochondrial energy metabolism was observed in both brain and peripheral tissues of G2019S LRRK2 knockin mice, potentially reflecting a compensatory response to cellular stress or damage. High-fat diet exposure induced systemic metabolic dysregulation in G2019S LRRK2 knockin mice, accompanied by hepatic lipid accumulation, pulmonary inflammation, and neuroinflammatory responses in the brain. The combined effects of inflammation and the G2019S mutation revealed disruption of central carbon and nucleotide metabolism in the lung, as well as alterations in energy metabolism, decreased dopamine levels, and aberrant glial responses in the brain. Potential functional validation experiments, including metabolic cage analysis, Seahorse mitochondrial respiration assays, and stable isotope-labeled substrate tracing, would be informative.

    Journal: NPJ Parkinson's Disease

    Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides

    doi: 10.1038/s41531-026-01465-x

    Figure Lengend Snippet: Thymidine phosphorylase levels were significantly increased in the liver of G2019S LRRK2 knockin mice, leading to systemic depletion of pyrimidine nucleosides, which may contribute to mitochondrial dysfunction. Under control diet conditions, increased mitochondrial energy metabolism was observed in both brain and peripheral tissues of G2019S LRRK2 knockin mice, potentially reflecting a compensatory response to cellular stress or damage. High-fat diet exposure induced systemic metabolic dysregulation in G2019S LRRK2 knockin mice, accompanied by hepatic lipid accumulation, pulmonary inflammation, and neuroinflammatory responses in the brain. The combined effects of inflammation and the G2019S mutation revealed disruption of central carbon and nucleotide metabolism in the lung, as well as alterations in energy metabolism, decreased dopamine levels, and aberrant glial responses in the brain. Potential functional validation experiments, including metabolic cage analysis, Seahorse mitochondrial respiration assays, and stable isotope-labeled substrate tracing, would be informative.

    Article Snippet: Primary antibodies used for Western blotting include: LRRK2 (75-253, NeuroMab), pS935-LRRK2 (ab133450, Abcam), pS1292-LRRK2 (ab203181, Abcam), Rab8 (D22D8, Cell Signaling Technology), pT72-Rab8a (ab230260, Abcam), Rab10 (8127S; Cell Signaling Technology), pThr73-Rab10 (ab230261, Abcam), Rab12 (18843-1-AP, Protein Tech), pSer106-Rab12 (ab256487, Abcam), Actin (MAB1501, Millipore), Thymidine Phosphorylase (AF7568, Novus Biologicals).

    Techniques: Knock-In, Control, Mutagenesis, Disruption, Functional Assay, Biomarker Discovery, Analysis, Labeling

    HDAC2 enhances antimicrobial activities against E.coli in mice. (A) Bacterial loads in the blood were calculated in HDAC2-knockout and wild type mice. (A)The picture of the bacterial clones was taken by BIO-RAD ChemiDoc“MP Imaging System. (B)The number of colony-forming units (CFU) in the blood of mice was calculated. HDAC2 WT and HDAC2 KO mice were administrated with E. coli- GFP (5 × 10 7 ) by intravenous Injection. Blood (20 μl) was taken from the tail vein of the mice, applied to the pretreated solid MHA medium, and incubated at 37 °C for 20 h. Count the colonies on the culture medium and take pictures. The experiments were performed in quintuplicate, data are presented as the means ± SEM. of independent experiments. *P < 0.05, **P < 0.01 (two-tailed Student’s t -test). (B) Bacterial loads in the kidneys were calculated in HDAC2-knockout and wild type mice. The picture of kidneys from HDAC2 WT and HDAC2 KO mice were taken. The number of colony-forming units (CFU) in the kidneys of mice was calculated. The kidneys from HDAC2 KO and HDAC2 WT mice were weighed, ground, spread on the MHA plates, incubated for 16–24 h at 37 °C, and then bacterial clones were counted. The experiments were performed in quintuplicate, data are presented as the means ± SEM. of independent experiments. *P < 0.05, **P < 0.01 (two-tailed Student’s t -test). n = 5 mice per group. (C) H&E staining of livers and kidneys. The arrows indicate damage section of tissue. (D) Serum CRP and PCT levels of mice with E. coli- GFP bacteremia at 24 h. The CRP and PCT were measured by ELISA. Data are shown as mean ± SEM. *p < 0.05; n = 5 mice per group. ns, not significant.

    Journal: Journal of Advanced Research

    Article Title: HDAC2 enhances the antimicrobial activity of neutrophils by promoting the formation of neutrophil extracellular traps (NETs) in sepsis

    doi: 10.1016/j.jare.2025.08.041

    Figure Lengend Snippet: HDAC2 enhances antimicrobial activities against E.coli in mice. (A) Bacterial loads in the blood were calculated in HDAC2-knockout and wild type mice. (A)The picture of the bacterial clones was taken by BIO-RAD ChemiDoc“MP Imaging System. (B)The number of colony-forming units (CFU) in the blood of mice was calculated. HDAC2 WT and HDAC2 KO mice were administrated with E. coli- GFP (5 × 10 7 ) by intravenous Injection. Blood (20 μl) was taken from the tail vein of the mice, applied to the pretreated solid MHA medium, and incubated at 37 °C for 20 h. Count the colonies on the culture medium and take pictures. The experiments were performed in quintuplicate, data are presented as the means ± SEM. of independent experiments. *P < 0.05, **P < 0.01 (two-tailed Student’s t -test). (B) Bacterial loads in the kidneys were calculated in HDAC2-knockout and wild type mice. The picture of kidneys from HDAC2 WT and HDAC2 KO mice were taken. The number of colony-forming units (CFU) in the kidneys of mice was calculated. The kidneys from HDAC2 KO and HDAC2 WT mice were weighed, ground, spread on the MHA plates, incubated for 16–24 h at 37 °C, and then bacterial clones were counted. The experiments were performed in quintuplicate, data are presented as the means ± SEM. of independent experiments. *P < 0.05, **P < 0.01 (two-tailed Student’s t -test). n = 5 mice per group. (C) H&E staining of livers and kidneys. The arrows indicate damage section of tissue. (D) Serum CRP and PCT levels of mice with E. coli- GFP bacteremia at 24 h. The CRP and PCT were measured by ELISA. Data are shown as mean ± SEM. *p < 0.05; n = 5 mice per group. ns, not significant.

    Article Snippet: Concentrations of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), histone deacetylase 2 (HDAC2), PCT, CRP and myeloperoxidase (MPO) in mouse serum were quantified using their respective enzyme-linked immunosorbent assay (ELISA) kits, following the protocols provided by the manufacturer (Boster Biological Technology, Wuhan, China).

    Techniques: Knock-Out, Clone Assay, Imaging, Injection, Incubation, Two Tailed Test, Staining, Enzyme-linked Immunosorbent Assay

    The cleaved form of the Cav1.3-C-terminus is localized within the nucleus. ( A ) Schematic representation of the Cav1.3 α1 subunit with the four domains (I–IV), six repeat segments (1–6), pore region (P), N-terminus (brown), intracellular loops (IC, green) and the C-terminus (C-term, blue) with the relevant regulatory domains (Isoleucine-glutamine (IQ); EF-Helix binding motif (EF hand)). The commercial anti-II-III loop and anti-C-terminus antibodies’ epitope are shown in red. Anti-Ca v 1.3-C-terminus antibody labeling shows green fluorescent staining of the nucleus and the cytoplasm in ( B ) non-infected neonatal rat myocytes (NRVMs), ( E ) non-infected adult rat atrial myocytes (ARAMs) and ( H ) Ca v 1.3-transfected tsA201 cells. DAPI in blue ( C , F ) and red ( I ) is a nuclear staining marker. Arrows indicate nuclear staining. Overlay images are shown in ( D , G , J ). The scale bar is 20 μm. ( K ) Surface plot illustrating the staining intensity of the C-terminus in the nucleus and cytoplasm using the anti-C-terminus antibody. The central gray peak corresponds to nuclear green fluorescence. ( L ) Representative Western blots of nuclear and cyptoplasmic fractions from non-infected NRVMs and ARAMs probed with the C-terminus antibody (n = 5). Histone Deacetylase (HDAC) and Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) were used as internal controls.

    Journal: Cells

    Article Title: C-Terminus of Ca v 1.3 L-Type Ca 2+ Channel Upregulates Its Own Gene Expression

    doi: 10.3390/cells15090828

    Figure Lengend Snippet: The cleaved form of the Cav1.3-C-terminus is localized within the nucleus. ( A ) Schematic representation of the Cav1.3 α1 subunit with the four domains (I–IV), six repeat segments (1–6), pore region (P), N-terminus (brown), intracellular loops (IC, green) and the C-terminus (C-term, blue) with the relevant regulatory domains (Isoleucine-glutamine (IQ); EF-Helix binding motif (EF hand)). The commercial anti-II-III loop and anti-C-terminus antibodies’ epitope are shown in red. Anti-Ca v 1.3-C-terminus antibody labeling shows green fluorescent staining of the nucleus and the cytoplasm in ( B ) non-infected neonatal rat myocytes (NRVMs), ( E ) non-infected adult rat atrial myocytes (ARAMs) and ( H ) Ca v 1.3-transfected tsA201 cells. DAPI in blue ( C , F ) and red ( I ) is a nuclear staining marker. Arrows indicate nuclear staining. Overlay images are shown in ( D , G , J ). The scale bar is 20 μm. ( K ) Surface plot illustrating the staining intensity of the C-terminus in the nucleus and cytoplasm using the anti-C-terminus antibody. The central gray peak corresponds to nuclear green fluorescence. ( L ) Representative Western blots of nuclear and cyptoplasmic fractions from non-infected NRVMs and ARAMs probed with the C-terminus antibody (n = 5). Histone Deacetylase (HDAC) and Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) were used as internal controls.

    Article Snippet: Briefly, cardiac cells were fixed, permeabilized, blocked, and incubated overnight at 4 °C with a primary anti-C-terminus antibody (Pacific Immunology, Ramona, CA, USA) targeting a unique epitope (amino acids 1708–1724) in the C-terminus of Ca v 1.3 and detected with FITC-conjugated anti-rabbit antibody (1:200).

    Techniques: Binding Assay, Antibody Labeling, Staining, Infection, Transfection, Marker, Fluorescence, Western Blot, Histone Deacetylase Assay